<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: liver</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>'Fasting pathway' points the way to new class of diabetes drugs</title>
   	 <description>A uniquely collaborative study by researchers at the Salk Institute for Biological Studies uncovered a novel mechanism that turns up glucose production in the liver when blood sugar levels drop, pointing towards a new class of drugs for the treatment of metabolic disease.</description>
     <link>http://medicalxpress.com/news/2011-05-fasting-pathway-class-diabetes-drugs.html</link>
	 <category>Medical research</category>
	 <pubDate>Thu, 12 May 2011 12:25:32 EST</pubDate>
	 <guid isPermaLink="false">news224421912</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2011/fastingpathw.jpg" width="90" height="85" />
</item>
<item>
     <title>Taking additional selenium will not reduce cancer risk</title>
   	 <description>Although some people believe that taking selenium can reduce a person's risk of cancer, a Cochrane Systematic Review of randomised controlled clinical trials found no protective effect against non-melanoma skin cancer or prostate cancer. In addition, there is some indication that taking selenium over a long period of time could have toxic effects.</description>
     <link>http://medicalxpress.com/news/2011-05-additional-selenium-cancer.html</link>
	 <category>Cancer</category>
	 <pubDate>Wed, 11 May 2011 03:57:34 EST</pubDate>
	 <guid isPermaLink="false">news224304993</guid>
	 
</item>


</channel>
</rss>
